Pharmafile Logo
Pharmafocus logo
Advanced Search

Lonza

Showing 15 posts of 55 posts found.

Lonza signs regenerative medicine deal with Mesoblast

September 27, 2011
Manufacturing and Production Lonza, Mesoblast, pharma manufacturing news

Lonza has entered into a strategic-level alliance with Mesoblast, a specialist in regenerative medicines, which could see the construction of …

News

Lonza profits slide as exchange rates bite

August 9, 2011
Manufacturing and Production CMO, Lonza

A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …

News

Lonza wins another antibody contract

July 19, 2011
Manufacturing and Production Immune Pharmaceuticals, Lonza, pharma manufacturing news

Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …

News

Lonza buys Arch Chemicals for $1.2 billion

July 12, 2011
Manufacturing and Production Lonza, pharma manufacturing news

Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …

News

Pharma manufacturing news in brief

May 31, 2011
Manufacturing and Production Aurobindo Pharma, Gallus, Lonza, ProMetic, Unigene

This week’s round-up of pharmaceutical manufacturing news includes new contracts for ProMetic and Unigene, plus facility updates from Aurobindo, Gallus …

News
Lonza Visp Switzerland

Lonza invests again in Visp high-potency capacity

May 17, 2011
Manufacturing and Production APIs, HPAPIs, Lonza, manufacturing and production

Lonza has pushed further into the high-potency active pharmaceutical ingredient (HPAPI) sector with another round of investment at its manufacturing …

News
Lonza, Slough

Lonza expands UK facility, bio business reports growth

April 13, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …

News

Lonza wins two biomanufacturing contracts

March 22, 2011
Manufacturing and Production Athera Biotechnologies, ENB-0040, Enobia Pharma, Lonza, PC-mAb, asfotase alfa, contract manufacturing, pharma, pharmaceuticals

Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make …

News

Pharma manufacturing news in brief

November 23, 2010
Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche

Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …

News

Lonza says contract manufacturing business is recovering

November 2, 2010
Manufacturing and Production API, Lonza, contract manufacturing, pharma manufacturing

Lonza said its contract manufacturing business seems to be enjoying a return to form in the third quarter, despite continued …

News

GSK paves way for biopharmaceuticals growth

September 9, 2010
Research and Development GlaxoSmithKline, Lonza, biologics

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …

News

Lonza buys Vivante to get bigger in biologics

August 31, 2010
Manufacturing and Production Lonza, Vivante

Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …

News

Cell therapy industry partnership launched

August 18, 2010
Research and Development Genzyme, ISCT, Lonza, Roche

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …

News

Lonza boosts profit despite contract manufacturing downturn

July 23, 2010
Manufacturing and Production 2010 financials, Lonza, Q2

Switzerland’s Lonza posted a healthy increase in profits in the first half of 2010, topping analysts’ expectations, although sales dipped …

News

Lonza wins two biologic contracts

July 16, 2010
Manufacturing and Production Elusys, Human Genome Sciences, Lonza

Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026